|
|
Volumn 93, Issue 20, 2001, Pages 1519-
|
|
Rapamycin may prevent Post-Transplant Lymphoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN;
RAPAMYCIN;
RAPAMYCIN DERIVATIVE;
TACROLIMUS;
TEMSIROLIMUS;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG MARKETING;
EPSTEIN BARR VIRUS;
HEART TRANSPLANTATION;
HUMAN;
KIDNEY TRANSPLANTATION;
LYMPHOMA;
LYMPHOPROLIFERATIVE DISEASE;
METASTASIS;
MOUSE;
NONHODGKIN LYMPHOMA;
NONHUMAN;
NOTE;
ORGAN TRANSPLANTATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
|
|
EID: 0035904334
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/93.20.1519 Document Type: Note |
|
Times cited : (16)
|
|
References (0)
|